| Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer JM Araujo, AC Gomez, A Aguilar, R Salgado, JM Balko, L Bravo, F Doimi, ... Scientific reports 8 (1), 4899, 2018 | 121 | 2018 |
| Treatment of cervical intraepithelial lesions PE Castle, D Murokora, C Perez, M Alvarez, SC Quek, C Campbell International Journal of Gynecology & Obstetrics 138, 20-25, 2017 | 110 | 2017 |
| In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies JA Pinto, C Rolfo, LE Raez, A Prado, JM Araujo, L Bravo, W Fajardo, ... Scientific reports 7 (1), 1526, 2017 | 86 | 2017 |
| Control of cervical cancer in Peru: Current barriers and challenges for the future A Aguilar, JA Pinto, J Araujo, W Fajardo, L Bravo, L Pinillos, C Vallejos Molecular and Clinical Oncology 5 (2), 241-245, 2016 | 51 | 2016 |
| Human genome meeting 2016: Houston, TX, USA. 28 February-2 March 2016 AK Srivastava, Y Wang, R Huang, C Skinner, T Thompson, L Pollard, ... Human genomics 10 (Suppl 1), 12, 2016 | 34 | 2016 |
| Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer JM Araujo, A Prado, NK Cardenas, M Zaharia, R Dyer, F Doimi, L Bravo, ... Oncotarget 7 (15), 20282, 2016 | 31 | 2016 |
| Patterns of mutation enrichment in metastatic triple-negative breast cancer CH Saravia, C Flores, LJ Schwarz, L Bravo, J Zavaleta, J Araujo, ... Clinical Medicine Insights: Oncology 13, 1179554919868482, 2019 | 30 | 2019 |
| The hispanic landscape of triple negative breast cancer A Zevallos, L Bravo, D Bretel, K Paez, U Infante, N Cardenas, H Alvarado, ... Critical reviews in oncology/hematology 155, 103094, 2020 | 26 | 2020 |
| Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America JA Pinto, CH Saravia, C Flores, JM Araujo, D Martínez, LJ Schwarz, ... ecancermedicalscience 13, 896, 2019 | 14 | 2019 |
| Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru Y Ferreyra, G Rosas, AM Cock-Rada, J Araujo, L Bravo, F Doimi, J Casas, ... Frontiers in Oncology 13, 1227864, 2023 | 9 | 2023 |
| Sources of contamination and enrichment of metals in the sediments of the Lerma-Chapala basin AM Hansen, A León, L Bravo Ingeniería Hidráulica en México 10 (3), 55-69, 1995 | 9 | 1995 |
| Expression of DDIT4 Is Correlated with NOTCH1 and High Molecular Risk in Acute Myeloid Leukemias JA Pinto, L Bravo, LA Chirinos, CE Vigil Blood, The Journal of the American Society of Hematology 128 (22), 5254-5254, 2016 | 6 | 2016 |
| Host-pathogen interaction: biology and public health R Ponce-Cusi, L Bravo, KJ Paez, JA Pinto, N Pilco-Ferreto Host-Pathogen Interactions: Methods and Protocols, 3-18, 2024 | 3 | 2024 |
| Recurrent abdominal panniculitis in a Peruvian man. V Maco, L Bravo, LA Marcos International Journal of Dermatology 55 (10), 2016 | 2 | 2016 |
| Desarrollo de competencias profesionales en los estudiantes de ingeniería agropecuaria de la Facultad de Ciencias Agropecuarias, Universidad nacional de Córdoba C Pen, E Armand, T Navarro, Z Karki, L Bravo, I Anconetani, ... | 1 | 2020 |
| Evaluation of RNA Polymerase I Subunit C gene (POLR1C) as prognostic biomarker in cancer. JS Torres-Roman, A Prado, CH Saravia, L Usquiano, J Zavaleta, L Bravo Journal of Clinical Oncology 36 (15_suppl), e24325-e24325, 2018 | 1 | 2018 |
| Impact of the COVID-19 Pandemic on the Treatment of Cancer Patients at a Hospital in Peru L Bravo, K Vizcarra, J Zavaleta, KJ Paez, Z Morante, A Limache-García, ... Cancer Control 31, 10732748241276616, 2024 | | 2024 |
| Abstract P3-12-24: Landscape of germline BRCA1 and BRCA2 mutations in breast cancer in Peru JA Pinto, Y Ferreyra, AM Cock-Rada, F Doimi, J Casas, J Araujo, G Rosas, ... Cancer Research 82 (4_Supplement), P3-12-24-P3-12-24, 2022 | | 2022 |
| Safety of immunotherapy in Peruvian patients with diverse type of malignancies: Experience at a private center. A Aguilar, M Mariñas, L Bravo, J Zavaleta, J Pinto, R Ruiz, L Schwarz Journal of Clinical Oncology 38 (15_suppl), e19258-e19258, 2020 | | 2020 |
| Decrease of benefit from immune checkpoint inhibitors in women with non-small cell lung cancer JA Pinto, LA Mas, CS Vallejos, J Araujo, L Bravo, A Aguilar, Z Morante, ... Cancer Research 77 (13_Supplement), 2614-2614, 2017 | | 2017 |
Joseph A. PintoOncosalud-AUNAVerified email at gecoperu.org
